Discover
The Journal of Clinical and Aesthetic Dermatology
James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab
Update: 2024-10-18
Share
Description
Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.
Comments
In Channel